GoodRx Holdings Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio109.17
Forward P/E27.04267.21
P/S Ratio2.263.632.4117.4928.67
P/B Ratio2.473.572.2715.6722.19
Price/Tangible Book13.0613.968.6835.4040.12
Price/FCF9.8019.8312.9374.83142.50
Price/OCF9.7319.6812.5872.91120.20
PEG Ratio1.878.72
Enterprise Value Ratios
EV/Revenue2.413.522.3717.2028.05
EV/EBITDA19.1939.3138.17358.80
EV/EBIT22.1652.7391.74956.68
EV/FCF10.4619.2212.7173.62139.42
Profitability & Returns
Return on Equity (ROE)0.02%-0.01%-0.04%-0.03%-1.63%
Return on Assets (ROA)0.04%0.02%0.01%0.01%-0.18%
Return on Invested Capital (ROIC)0.06%0.06%0.03%0.03%-0.70%
Return on Capital Employed (ROCE)0.07%0.03%0.01%0.01%-0.19%
Leverage & Solvency Ratios
Debt/Equity0.750.930.880.840.99
Debt/EBITDA5.059.4713.3316.99
Debt/FCF2.985.185.024.036.36
Liquidity Ratios
Current Ratio5.327.1212.0513.4218.24
Quick Ratio5.106.9211.5213.1617.90
Efficiency Ratios
Asset Turnover0.530.470.480.480.59
Yield & Distribution Ratios
Earnings Yield0.01%0.00%-0.02%0.00%-0.02%
FCF Yield0.10%0.05%0.08%0.01%0.01%
Buyback Yield0.04%0.01%-0.01%-0.49%-0.19%